| Literature DB >> 28341980 |
Lélia Dreyfus1, Etienne Javouhey2,3, Angélique Denis4, Sandrine Touzet4,5, Fabienne Bordet2.
Abstract
BACKGROUND: Optimal sedation and analgesia is a challenge in paediatric intensive care units (PICU) because of difficulties in scoring systems and specific metabolism inducing tolerance and withdrawal. Excessive sedation is associated with prolonged mechanical ventilation and hospitalisation. Adult and paediatric data suggest that goal-directed sedation algorithms reduce the duration of mechanical ventilation. We implemented a nurse-driven sedation protocol in a PICU and evaluated its impact.Entities:
Keywords: Benzodiazepine; COMFORT-B score; Evaluation; Feasibility; Mechanical ventilation; Nurse-driven sedation protocol; Opioid; PICU; Withdrawal symptoms
Year: 2017 PMID: 28341980 PMCID: PMC5366991 DOI: 10.1186/s13613-017-0256-7
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Fig. 1Nurse-driven sedation protocol
Patient characteristics over the study period
| Pre-implementation | Post-implementation |
| |
|---|---|---|---|
| Male, | 61 (59) | 57 (61) | 0.706 |
| Age at admission (years), mean (SD) | 4.9 (5.4) | 5.2 (5.3) | 0.607 |
| Median [Q1–Q3] | 2.2 [0.4–9.6] | 3.2 [0.4–9.7] | |
| Weight at admission (kg), mean (SD) | 20.3 (18.9) | 20.7 (17.8) | 0.660 |
| Reason for admission, | |||
| Surgical cause | 25 (24) | 35 (38) | 0.039 |
| Non-surgical cause | 79 (76) | 58 (62) | 0.131 |
| Neurology | 41 (39) | 28 (27) | |
| Respiratory | 29 (29) | 22 (21) | |
| Sepsis | 9 (9) | 8 (8) | |
| Medical history, | 18 (17) | 15 (16) | 0.825 |
| Prematurity <34 weeks | 8 (8) | 4 (4) | 0.267 |
| Chronic respiratory failure | 1 (1) | 3 (3) | 0.345 |
| Congenital cardiopathy | 5 (5) | 6 (6) | 0.616 |
| Chronic cardiac failure | 0 (0) | 2 (2) | 0.212 |
| Encephalopathy | 8 (8) | 5 (5) | 0.513 |
| PELOD score, mean (SD) | 18.8 (11.6) | 17.5 (11.6) | 0.746 |
| Death, | 18 (17) | 13 (14) | 0.522 |
| Inotropic drugs, | 75 (72) | 67 (72) | 0.991 |
| Neuromuscular blockade, | 38 (37) | 33 (35) | 0.878 |
| Dialysis, | 2 (2) | 4 (4) | 0.424 |
| Unplanned extubation, | 4 (4) | 3 (3) | 1.000 |
* Reason for admission: p = 0.039 is the p value of the difference between surgical and non-surgical admission diagnosis; p = 0.131 is the p value of the difference within the non-surgical admission diagnosis (neurology, respiratory, and sepsis)
Duration of mechanical ventilation, PICU length of stay, and medication uses over the study period
| Pre-implementation | Post-implementation |
| |
|---|---|---|---|
| Duration of mechanical ventilation (days) | 5.6 (3.2–10.5) | 4.8 (2.8–8.3) | 0.094 |
| PICU length of stay (days) | 9.0 (5.0–15.2) | 9.8 (4.9–14.5) | 0.767 |
| Sufentanil | |||
| Daily dose (μg/kg/day) | 5.6 (3.8–8.7) | 6.3 (4.7–8.7) | 0.185 |
| Duration of administration (h) | 99 (54–170) | 78 (47–133) | 0.097 |
| Midazolam | |||
| Daily dose (mg/kg/day) | 3.2 (2.1–4.9) | 2.9 (2.2–4.4) | 0.223 |
| Duration of administration (h) | 112 (60–171) | 89 (44–155) | 0.149 |
| Ketamine | |||
| Daily dose (mg/kg/day) | 46.1 (29.6–57.1) | 41.9 (24.3–51.3) | 0.067 |
| Duration of administration (h) | 110 (54–167) | 94 (46–155) | 0.574 |
Quantitative variables are expressed as median (quartiles Q1–Q3). P values were calculated using Wilcoxon’s test
Fig. 2Mean number of COMFORT-B assessment per day on mechanical ventilation over time. Observed data are presented with black dots, and predicted data with segmented regression analysis are presented in blue for pre-implementation and red for post-implementation. Vertical dashed lines represent the 4-month implementation period
Fig. 3Distribution of COMFORT-B scores per level of sedation and analgesia before and after the protocol implementation. Bars represent 95% confidence interval, ***p < 0.001
Analysis of changes in the level and trend in outcomes after implementation of the nurse-driven sedation protocol
| Outcomes | Pre-implementation period | Post-implementation period | ||||
|---|---|---|---|---|---|---|
| Overall trend before the implementation of protocola |
| Immediate change after the implementation of protocolb |
| Change in trend after the implementation of protocolc |
| |
| Duration of mechanical ventilation (days) | −0.35 (0.42) | 0.450 | 0.17 (1.64) | 0.923 | −0.05 (0.60) | 0.933 |
| PICU length of stay (days) | −0.71 (0.90) | 0.476 | 6.56 (3.49) | 0.134 | −1.07 (1.28) | 0.450 |
| Sufentanil | ||||||
| Daily dose (μg/kg/day) | 0.19 (0.31) | 0.574 | 0.38 (1.22) | 0.770 | −0.21 (0.44) | 0.668 |
| Duration of administration (h) | −3.31 (4.79) | 0.528 | −1.42 (18.6) | 0.943 | −1.32 (6.78) | 0.855 |
| Midazolam | ||||||
| Daily dose (mg/kg/day) | −0.12 (0.18) | 0.541 | 0.04 (0.69) | 0.955 | 0.02 (0.25) | 0.944 |
| Duration of administration (h) | 0.27 (3.59) | 0.944 | −13.4 (13.9) | 0.389 | −3.39 (5.07) | 0.541 |
| Ketamine | ||||||
| Daily dose (mg/kg/day) | 1.11 (2.96) | 0.727 | 1.97 (11.5) | 0.872 | −3.06 (4.19) | 0.506 |
| Duration of administration (h) | 7.06 (21.2) | 0.756 | −4.82 (82.1) | 0.956 | −17.2 (30.0) | 0.598 |
Negative numbers represent a decline, and inversely, positive numbers represent an increase in outcomes values
aMean change (standard deviation in brackets) of each outcome per semester before the implementation of the protocol
bExpressed as a mean change (standard deviation in brackets) of each outcome immediately after implementation of the nurse-driven protocol compared with the pre-implementation period
cMean change (standard deviation in brackets) of each outcome per semester after the implementation of the protocol compared with the pre-implementation period
Fig. 4Duration of mechanical ventilation over time. Observed data are black dots, and predicted data with segmented regression analysis are blue for pre-implementation and red for post-implementation. Vertical dashed lines represent the 4-month implementation period